ArticleNPJ artificial intelligence2026
SPARROW: subtyping Parkinson's disease with agentic reasoning and robust omics workflow.
Article in NPJ artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder that presents a wide spectrum of clinical phenotypes, posing a fundamental challenge for early and accurate subtyping. This requires a multimodal assessment to identify disease patterns. Robust integration of multi-omics data, brain MRI, clinical biomarkers and cognitive assessments remains challenging, especially when data are missing or incomplete. Existing tools often lack domain-driven reasoning and offer limited interpretability, undermining their clinical utility. This paper presents SPARROW, a multimodal framework that unifies genomic, imaging, clinical and cognitive data in a common semantic knowledge space for PD subtyping. Within SPARROW, specialist modules for omics and MRI analysis provide structured ontology-driven outputs that a large language model-based reasoner then interprets via chain-of-thought reasoning. This approach achieves transparency in subtype decisions by highlighting how each data source contributes to the final classification. Applied to the Parkinson's Progression Markers Initiative (PPMI) dataset, SPARROW achieved superior performance on classification of all subtypes using the baseline visit data in a zero-shot setting. Our findings underscore the potential of SPARROW for accurate and interpretable PD subtyping in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.